To determine the molecular mechanism by which UBE2C and ZEB1/2 reverses DDP resistance in lung cancer cells, we conducted RT-PCR to confirm whether ZEB1/2 regulates the drug resistance genes HER2, MRP1, KRAS, BRCA1, and MDR1 in A549/DDP cells. This evidence concerns the gene ZEB1 and lung carcinoma.